On November 9, 2022 Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of Master Key therapies, reported that company management will participate in three upcoming investor conferences (Press release, Black Diamond Therapeutics, NOV 9, 2022, View Source [SID1234623526]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The H.C. Wainwright 3rd Annual Precision Oncology Virtual Conference. The fireside chat will take place on Monday, November 14, 2022, at 12:00 PM ET.
The Stifel 2022 Healthcare Conference. The presentation will take place on Tuesday, November 15, 2022, at 2:25 PM ET in New York, New York.
The Piper Sandler 34th Annual Healthcare Conference. The presentation will take place on Thursday, December 1, 2022, at 9:30 AM ET in New York, New York.
A webcast of each event can be accessed by visiting the investors relations section of the Company’s website at: www.blackdiamondtherapeutics.com. A replay of the webcasts will also be available and archived on for 90 days following the events.